| Breakdown | TTM | Apr 2025 | Apr 2023 | Apr 2022 | Apr 2020 | Apr 2018 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.97B | 4.93B | 5.56B | 4.69B | 3.96B | 3.36B |
| Gross Profit | 2.43B | 2.31B | 2.37B | 2.04B | 1.37B | 1.34B |
| EBITDA | 1.02B | 778.70M | 976.20M | 609.70M | 478.00M | 245.60M |
| Net Income | 467.70M | 292.10M | 491.70M | 249.80M | 93.80M | 24.50M |
Balance Sheet | ||||||
| Total Assets | 6.07B | 5.13B | 4.29B | 4.14B | 3.87B | 2.89B |
| Cash, Cash Equivalents and Short-Term Investments | 359.80M | 252.20M | 332.90M | 336.80M | 534.00M | 360.00M |
| Total Debt | 2.33B | 1.86B | 1.43B | 1.45B | 1.52B | 757.10M |
| Total Liabilities | 3.68B | 3.14B | 2.63B | 2.83B | 2.59B | 1.70B |
| Stockholders Equity | 2.36B | 1.96B | 1.62B | 1.29B | 1.27B | 1.19B |
Cash Flow | ||||||
| Free Cash Flow | 292.60M | 531.70M | 44.90M | 159.20M | 45.20M | 122.00M |
| Operating Cash Flow | 669.20M | 943.40M | 514.30M | 482.40M | 368.70M | 326.20M |
| Investing Cash Flow | -730.70M | -1.21B | -201.40M | -123.50M | -203.70M | -364.70M |
| Financing Cash Flow | 91.00M | 161.90M | -320.40M | -479.20M | -84.00M | 259.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £3.15B | 6.78 | 21.64% | ― | -6.43% | 52.93% | |
73 Outperform | £1.64B | 12.68 | 5.88% | 1.18% | 9.51% | -31.96% | |
73 Outperform | £4.10B | 9.70 | 15.14% | 1.21% | 10.51% | -9.26% | |
68 Neutral | £797.88M | 12.82 | 6.50% | 6.51% | -0.84% | -27.69% | |
65 Neutral | £1.64B | 10.97 | 105.88% | 3.99% | 4.39% | -1.37% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
44 Neutral | £597.55M | -3.90 | -90.46% | 4.48% | -30.52% | -2064.92% |